PMO Monomers

(9 products)
Base O N O P N O Cl

General structure of PMO Monomer

What are PMO Monomers?
PMO (Phosphorodiamidate Morpholino) monomers are specialized synthetic units designed for constructing morpholino oligonucleotides. Each monomer consists of three essential components: a morpholino ring that replaces the natural sugar moiety while maintaining base-pairing capability, a nucleobase (adenine, cytosine, guanine, thymine, or uracil) for specific recognition, and a phosphorodiamidate linkage that forms the oligonucleotide backbone. This unique architecture provides exceptional RNA binding affinity and nuclease resistance.

General Synthesis Approach
PMO monomers are synthesized through a multi-step organic synthesis process:

  • Morpholino ring formation from protected sugar precursors
  • Nucleobase incorporation via stereospecific coupling reactions
  • Phosphorodiamidate moiety installation through phosphitylation and oxidation
  • Protective group introduction (typically Fmoc or trityl groups) for controlled oligomerization

Application in Synthesis
PMO monomers are specifically designed for solid-phase oligonucleotide synthesis:

  • Automated Oligonucleotide Assembly: Used in standard DNA synthesizers with modified protocols for stepwise chain elongation
  • Solid-Phase Synthesis: monomers are sequentially added to a growing chain attached to solid support (e.g., controlled pore glass)
  • Deprotection-Coupling Cycles: Each addition cycle involves temporary protecting group removal, monomer coupling, and capping steps
  • Final Processing: Completed oligonucleotides are cleaved from support and purified for downstream applications

This synthesis approach enables production of PMO oligonucleotides for therapeutic and research applications, particularly benefiting from the monomers' enhanced stability and binding properties.

Our Advantages


Scalable Synthesis Capacity

To support projects at every stage, we provide PMO Monomer synthesis across a comprehensive scale—from research grade to industrial scale.

High PMO Performance

Every monomer is synthesized to deliver the inherent benefits of PMO technology: exceptional nuclease resistance for superior stability in biological systems, high target specificity due to its neutral backbone, and a well-established safety profile.

Commitment to Purity & Quality

We guarantee high-purity (≥98%) products, underpinned by rigorous quality control. This ensures optimal performance, batch-to-batch consistency, and reliable results for your most critical applications.

Customization & Conjugation

We provide capabilities for tailored monomer synthesis and facile conjugation to enhance cellular delivery and targeting.

Powering Innovation Across Life Sciences

Our high-purity PMO monomers are critical for developing therapeutics and research tools in numerous areas:


Genetic Diseases

Synthesize critical components for siRNA, antisense oligonucleotides (ASOs), and aptamers for novel drug discovery and development. Our high-purity phosphoramidites ensure the reliability and efficacy of therapeutic oligonucleotides.

Antiviral Therapeutics

Produce highly specific PCR primers, probes, and capture sequences for molecular diagnostics and genetic testing. Achieve exceptional accuracy and reproducibility with our consistent quality.

Oncology

Enable foundational research in genomics, including gene synthesis, mutagenesis studies, and NGS library preparation. Our products support academic and industrial research with reliable performance.

Neurological Disorders

Targeting RNA involved in diseases such as Huntington's disease and Amyotrophic Lateral Sclerosis (ALS).

Research Tools

Used in the development of FISH probes, qPCR blockers, and functional genomics research

View as

Compare /8

Loading...

My Wishlist